Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Extracellular vesicle-based point-of-care testing for diagnosis and monitoring of Alzheimer’s disease

Open access

Published version of a preprint

Abstract

Extracellular vesicles (EVs) show potential for early diagnosis of Alzheimer's disease (AD) and monitoring of its progression. However, EV-based AD diagnosis faces challenges due to the small size and low abundance of biomarkers. Here, we report a fully integrated organic electrochemical transistor (OECT) sensor for ultrafast, accurate, and convenient point-of-care testing (POCT) of serum EVs from AD patients. By utilizing acoustoelectric enrichment, the EVs can be quickly propelled, significantly enriched, and specifically bound to the OECT detection area, achieving a gain of over 280 times response in 30 s. The integrated POCT sensor can detect serum EVs from AD patients with a limit of detection as low as 500 EV particles/mL and a reduced detection time of just two minutes. Furthermore, the integrated POCT sensors were used to monitor AD progression in an AD mouse model by testing the mouse Aβ EVs at different time courses (up to 18 months) and compared with the Aβ accumulation using high-resolution magnetic resonance imaging (MRI). This innovative technology has the potential for accurate and rapid diagnosis of Alzheimer's and other neurodegenerative diseases, and monitoring of disease progression and treatment response.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41378-025-00916-4

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Point of care testing (POCT) of serum extracellular vesicles (EVs) in Alzheimer’s disease (AD). a Workflow of an integrated POCT sensor for diagnosis and monitoring progression of AD. b Photo of an integrated sensor device with an organic electrochemical transistor (OECT) sensing unit and an acoustoelectric EV enrichment unit (left), and image of the OECT sensor (middle) with source (SE), drain (DE), and gate electrodes (GE), respectively. Scale bar, 500 μm. Working principle of the integrated sensor (right), target EVs can be rapidly enriched using focused surface acoustic waves (FSAWs) and electric pulses and further detected using an OECT coated with correlated antibodies. c Simulated distributions of acoustic and electric fields. Scale bar, 500 μm. d SEM images of EV distributions with the acoustoelectric enrichment (Acou.(+), Elec.(+)) and conventional condition (Acou.(−), Elec.(−)). Scale bar, 1 μm
Fig. 1 Point of care testing (POCT) of serum extracellular vesicles (EVs) in Alzheimer’s disease (AD). a Workflow of an integrated POCT sensor for diagnosis and monitoring progression of AD. b Photo of an integrated sensor device with an organic electrochemical transistor (OECT) sensing unit and an acoustoelectric EV enrichment unit (left), and image of the OECT sensor (middle) with source (SE), drain (DE), and gate electrodes (GE), respectively. Scale bar, 500 μm. Working principle of the integrated sensor (right), target EVs can be rapidly enriched using focused surface acoustic waves (FSAWs) and electric pulses and further detected using an OECT coated with correlated antibodies. c Simulated distributions of acoustic and electric fields. Scale bar, 500 μm. d SEM images of EV distributions with the acoustoelectric enrichment (Acou.(+), Elec.(+)) and conventional condition (Acou.(−), Elec.(−)). Scale bar, 1 μmCC BY-NC-ND · PubMed Central
Fig. 2 Acoustoelectric enrichment and sensing of EVs. a Schematics and experimental results of EV (red fluorescence-label) enrichment within the region of interest (ROI, red rectangle) under different conditions. Scale bar, 50 µm. b Fluorescent intensity of EVs extracted from the ROI’ (white dished rectangle). c Relative change of the drain current as a function of incubation time under different conditions (mean ± s.e.m., n = 4, independent experiments). The dashed curves indicate the response curves fitted using the exponential function. d The gain factor of each group with a duration time of 30 s (mean ± s.e.m., n = 4, independent experiments). The time constant (e) and saturation value (f) of the fitting curves in (c) (mean ± s.e.m., n = 4, independent experiments)
Fig. 2 Acoustoelectric enrichment and sensing of EVs. a Schematics and experimental results of EV (red fluorescence-label) enrichment within the region of interest (ROI, red rectangle) under different conditions. Scale bar, 50 µm. b Fluorescent intensity of EVs extracted from the ROI’ (white dished rectangle). c Relative change of the drain current as a function of incubation time under different conditions (mean ± s.e.m., n = 4, independent experiments). The dashed curves indicate the response curves fitted using the exponential function. d The gain factor of each group with a duration time of 30 s (mean ± s.e.m., n = 4, independent experiments). The time constant (e) and saturation value (f) of the fitting curves in (c) (mean ± s.e.m., n = 4, independent experiments)CC BY-NC-ND · PubMed Central
Fig. 3 Detection of serum EVs from AD patients using integrated POCT sensors. a Sensitivity of detecting tau EVs from AD serum (mean ± s.e.m., n = 3, independent experiments; LOD and LOQ indicate the limit of detection and quantitation, respectively). b Sensing results for AD serum from AD patients, health donors, EV-depleted serum, and PBS buffer, indicating the good specificity of the integrated POCT sensors (mean ± s.e.m., n = 3 or 4, independent experiments). c AD diagnosis based on serum from patients. The sensing results for purified EVs and serum from health donors and AD patients (mean ± s.e.m., n = 4, independent experiments)
Fig. 3 Detection of serum EVs from AD patients using integrated POCT sensors. a Sensitivity of detecting tau EVs from AD serum (mean ± s.e.m., n = 3, independent experiments; LOD and LOQ indicate the limit of detection and quantitation, respectively). b Sensing results for AD serum from AD patients, health donors, EV-depleted serum, and PBS buffer, indicating the good specificity of the integrated POCT sensors (mean ± s.e.m., n = 3 or 4, independent experiments). c AD diagnosis based on serum from patients. The sensing results for purified EVs and serum from health donors and AD patients (mean ± s.e.m., n = 4, independent experiments)CC BY-NC-ND · PubMed Central
Fig. 4 Monitoring of disease progression in a mouse model of Alzheimer’s disease (AD). a Examination of health mice and disease mice (5xFAD) under different disease stages/ages using MRI and the integrated POCT sensor, respectively. The profiling of Aβ42 + EVs is proposed for monitoring AD progression. b MRI images of AD (5xFAD) mice in 4–18 months and wild type (WT), and AD progression is indicated by the gradual increase of plaques in the hippocampus regions of AD mice (blue arrows) with age. c Quantitative results of plaque loading (%). No plague loading (0%) was detected in WT. d EV sensing results of healthy mice and AD mice at different ages using integrated POCT sensors. e Correlation graph between the EV sensing and MRI results. A strong correlation was observed from the pooled mice data (20 mice in total). The gray area indicates 95% prediction bands based on linear regression fitting (mean ± s.e.m., n = 5 mice per group, independent experiments)
Fig. 4 Monitoring of disease progression in a mouse model of Alzheimer’s disease (AD). a Examination of health mice and disease mice (5xFAD) under different disease stages/ages using MRI and the integrated POCT sensor, respectively. The profiling of Aβ42 + EVs is proposed for monitoring AD progression. b MRI images of AD (5xFAD) mice in 4–18 months and wild type (WT), and AD progression is indicated by the gradual increase of plaques in the hippocampus regions of AD mice (blue arrows) with age. c Quantitative results of plaque loading (%). No plague loading (0%) was detected in WT. d EV sensing results of healthy mice and AD mice at different ages using integrated POCT sensors. e Correlation graph between the EV sensing and MRI results. A strong correlation was observed from the pooled mice data (20 mice in total). The gray area indicates 95% prediction bands based on linear regression fitting (mean ± s.e.m., n = 5 mice per group, independent experiments)CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 17

Metadata

Authors
Li, X., Chen, J., Yang, Y., Cai, H., Ao, Z., Xing, Y., Li, K., Yang, K., Guan, W., Friend, J., Lee, L. P., Wang, N., & Guo, F.
Affiliations
  • Indiana University Bloomington (US)
  • The University of Texas Southwestern Medical Center (US)
  • Brigham and Women's Hospital (US)
  • University of California San Diego (US)
Corresponding author
  • Lee, Luke P.
  • Wang, Nian
  • Guo, Feng
Venue
Microsystems & Nanoengineering
Published
2025-04-17
Volume
11
Issue
1
Pages
65-65
ISSN
2055-7434 (ISSN-L)
OpenAlex
W4409521872
Cited by
17
References
75
Citations by year
2026: 9 · 2025: 8
FWCI
3.80
Type
journal article
Language
en
Open access
Licence
Locations
  • Microsystems & Nanoengineering (publishedVersion, cc-by-nc-nd)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • PubMed Central (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Institute of Health Awards
Topics
  • Physical Sciences › Chemistry › Analytical Chemistry › Electrochemical sensors and biosensors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
Keywords
extracellular vesicles, Alzheimer's disease, point-of-care testing, amyloid-beta, disease progression monitoring, neurodegenerative disease diagnosis, mouse model

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Extracellular vesicle-based point-of-care testing for diagnosis and monitoring of Alzheimer’s disease. https://app.cochat.ai/papers/10.1038/s41378-025-00916-4
The paper
Li, X., Chen, J., Yang, Y., Cai, H., Ao, Z., Xing, Y., Li, K., Yang, K., Guan, W., Friend, J., Lee, L. P., Wang, N., & Guo, F. (2025). Extracellular vesicle-based point-of-care testing for diagnosis and monitoring of Alzheimer’s disease. Microsystems & Nanoengineering. https://doi.org/10.1038/s41378-025-00916-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.